Early-Stage TNBC: What are the Roles of PARPIs?

Making a Difference in Survival: Integrating New Therapies for Triple-Negative Breast Cancer


Explore the latest groundbreaking treatment approaches for early-stage triple-negative breast cancer (TNBC) in this engaging tumor board!  The multidisciplinary panel of expert faculty will dive into a case involving a patient with early TNBC and discuss the latest data and potential roles of PARP inhibitors (PARPIs) in the first CME activity offered in this TNBC series.

Claim credit: https://www.achlcme.org/PARPis-tnbc-onctube

Access the three-part series: https://www.achlcme.org/triple-negative-breast-cancer